Trial intelligence / Profile preview

Huisheng oral liquid in the perioperative coagulation state of patients with primary lung cancer

ChiCTR-TRC-13003325Phase 4Completed

Sponsor
The Fourth Hospital of Hebei Medical University
Start
Jun 2013
Countries
1
01

Overview

Phase 4, randomised, open-label trial of Huisheng Oral Liquid in bronchial carcinoma (2 arms), sponsored by The Fourth Hospital of Hebei Medical University. Primary endpoints: Blood routine test, Prothrombin time and 6 more. Started Jun 2013; status: completed.

02

Drugs

Huisheng Oral Liquid
03

Conditions

bronchial carcinoma

Beyond the preview

Go deeper on ChiCTR-TRC-13003325.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-13003325.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call